MedTrace Logo

Ibuprofen and Renal Function in Premature Infants

NCT00217191 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-09-19

No results posted yet for this study

Summary

Purpose of the study:

1. To evaluate renal function maturation within the first month of life in very premature infants.
2. To determine whether a treatment with Ibuprofen for patent ductus arteriosus would alter renal function maturation at short term and up to 28 days of life.

Conditions

  • Premature Infants
  • Patent Ductus Arteriosus

Interventions

DRUG

Ibuprofen

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    collaborator OTHER

  • Ministere de la Sante et de la Protection Sociale, France

    collaborator UNKNOWN

  • Maternite Regionale Universitaire

    lead OTHER

Principal Investigators

  • Jean-Michel HASCOET, MD · University of Nancy, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
0 Years
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2006-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00217191 on ClinicalTrials.gov